Dhampur Bio Organics Limited (DBOL) — Board Meeting

📢 Key Event
Board approved Q3 FY2026 results and discontinued operations from Meerganj sale

🔄 What Changed
Net loss of ₹13.75 crores from continuing operations; gain of ₹63.89 crores on sale; no interim dividend declared

💡 Investor Takeaway
The company posted a loss in core operations but recorded overall profit due to the discontinued unit sale, with no dividend payout and new auditor appointment.

The Board approved unaudited consolidated financial results for Q3 FY2026 (ended June 30, 2026) showing revenue of ₹918.56 crores, total expenses of ₹938.06 crores, and a net loss of ₹13.75 crores from continuing operations before tax. Discontinued operations from the sold Meerganj unit generated a profit of ₹50.54 crores after tax, contributing to a total comprehensive income of ₹36.78 crores. The sale, finalized on June 18, 2026, for ₹305 crores, yielded a gain of ₹63.89 crores. The Board rejected an interim dividend and appointed Grant Thornton Bharat LLP as internal auditor for FY2026-27. Results were reviewed by the Audit Committee and confirmed with an unmodified limited review conclusion.

📄 View Original Announcement (PDF)

📊 Stock Analysis — DBOL ✨ Ask AI About This